The 2009 H1N1 influenza pandemic in Navarre, Spain;Caracterización de la pandemia de gripe A H1N1 2009 en Navarra

Anales del Sistema Sanitario de Navarra

Volumn 33, Issue 3, 2010, Pages 287-295

  Castilla, Jesús ^a,b   Moran J ^c   Fernandez Alonso M ^d   Martinez Artola V ^e   Zamora, M J ^f   Mazon A ^g   Fernandez C ^e   Garcia Cenoz M ^a,b   Elia F ^c   Reina, G ^d   Salcedo, E ^e   Irisarri, F ^a,b   Barricarte, A ^a,b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g Centro Sanitario Dr San Martín   (Spain)

Author keywords

Epidemiological Surveillance; Influenza; Pandemic; Public health

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ARTICLE; CHILD; DISEASE SURVEILLANCE; FLU LIKE SYNDROME; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; PRIMARY MEDICAL CARE; VIRUS DETECTION; ADULT; AGED; COMPARATIVE STUDY; FEMALE; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; PANDEMIC; PRESCHOOL CHILD; SPAIN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; SPAIN; YOUNG ADULT;

EID: 79960884185     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186.
3. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340.
4. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-1745.
5. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004; 160: 492-502.
6. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009. MMWR Recomm Rep 2009; 58: 1-52.
7. New influenza A/H1N1 virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84: 249-257.
8. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-2615.
9. Echeverría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León P et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374: 2072-2079.
10. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009; 325: 197-201.
11. ICPC-2. International Classification of Primary Care, 2nd edn. Oxford: Oxford University Press, 1998.
12. Lessler J, Reich NG, Cummings DAT and the New York City Department of Health and Mengal Hygiene Swine Influenza Investigation Team. Outbreak of 2009 pandemic influenza A (H1N1) at a New York city school. N Engl J Med 2009; 361: 2628-2636.
13. Zhao H, Joseph C, Phin N. Outbreaks of influenza and influenza-like illness in schools in England and Wales, 2005/06. Euro Surveill. 2007 May 1; 12 (5): E3-4.
14. Larrauri Cámara A, Jiménez-Jorge S, Simon Méndez L, de Mateo Ontañón S, en representación del Sistema de Vigilancia de Gripe en España (SVGE). Vigilancia de la pandemia de gripe (H1N1) 2009 en España. Rev Esp Salud Pública 2010; 84: 569-588.
15. Hancock K, Veguilla V, Lu X, Zhog W, Butler EN, Sun H et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-1962.
16. Castilla J, Arregui L, Baleztena J, Barricarte A, Brugos A, Carpintero M et al. Incidencia de la gripe y efectividad de la vacuna antigripal en la temporada 204-2005. An Sist Sanit Navar 2006; 29: 83-92.
17. The ANZIC influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925-1934.
18. Castilla J, Etxeberria J, Ardanaz E, Floristán Y, López Escudero R, Guevara M. Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain. Euro Survell 2010; 15 (5) pii=19481.
19. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009; 14: 150-154.
20. Centers for Disease Control and Prevention. Effectiveness of 2009-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)-United States, May-June 2009. MMWR 2009; 58: 1241-1245.
21. García-García L, Valdespino-Gómez JL, Lazcano-Ponce E, Jiménez-Corona A, Higuera-Iglesias A, Cruz-Hervent P et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339: b3928.
22. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N et al. Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four Observational Studies from Canada. PLoS Med 2010; 7 (4): e1000258. doi:10.1371/journal.pmed.1000258.
23. Johansen K, Nicoll A, Ciancio BC, Kramarz P. Pandemic influenza A(H1N1) 2009 vaccines in the European Union. Euro Surveill 2009; 14: 245-251.
24. World Health Organization. Mathematical modelling of the pandemic H1N1 2009. Wkly Epidemiol Rec 2009; 84: 341-348.
25. World Health Organization. Recommended virus for influenza vaccines for use in the 2010-2011 northern hemisphere influenza. Wkly Epidemiol Rec 2010; 85: 81-92.